Clinical Trials List
Protocol NumberNSC 95-2314-B-016-019-MY2
Phase I
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 9 2007 12:00AM participants
-
Global
participants
